NYSE · Healthcare · Medical Devices · USA
Globus Medical Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Devices industry.
Globus Medical develops and commercializes healthcare solutions for musculoskeletal disorders through hospitals, ambulatory surgery centers, and physicians worldwide. The company offers implantable devices, biologics, spinal cord stimulation therapy, and neuromonitoring services for spinal, orthopedic, and neurosurgical procedures. Operating across multiple countries, Globus sells primarily in the United States through direct representatives and distributors.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Globus Medical Inc stock.
Undervalued: intrinsic value $105.77 per share, market price $78.05, margin of safety 26.2% (as of 2026-10-30).
Discounting its cash flows at 10.0% (average of 3 methods) values the shares at $105.77; the price of $78.05 is 26% below that value, and 74% of that value comes from beyond year five.
Leak Score: 72/100 on 11 of 12 signals (Clear Leak).
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
5 more in this industry show a wider margin of safety.
GMED is undervalued (as of the 2026-10-30 close). Discounting its cash flows at 10.0% (average of 3 methods) values the shares at $105.77; the price of $78.05 is 26% below that value, and 74% of that value comes from beyond year five.
$105.77 per share (as of the 2026-10-30 close), against a market price of $78.05. That is a margin of safety of 26.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
72 out of 100, which we rate "Clear Leak", on 11 of 12 value investing signals.